Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05831345

Intraoperative Methadone for the Prevention of Postoperative Pain

Intraoperative Methadone for the Prevention of Postoperative Pain: a Randomized, Double-blind Clinical Study in Orthopedic Surgery

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The pain felt after orthopedic surgery in the absence of adequate locoregional anesthesia is often insufficiently controlled, especially during the first 24 hours postoperatively. Methadone, due to its long half-life, may provide better pain control after orthopedic surgery when associated locoregional anesthesia cannot be performed. It may be impossible to perform loco-regional anesthesia in various contexts: patient refusal, pre-existing neurological impairment, infection at the injection site, coagulopathies, inability to cooperate, total language barrier, allergy to anesthetics, unavailability of equipment (ultrasound, etc.) or equipped room, lack of experience of nursing staff in performing the block and in the postoperative management of the patient. Intraoperative administration of methadone in these settings may be superior to sufentanil for pain control during the 24 hours post orthopedic surgery, and the pain control provided by methadone does not appear to imply a higher likelihood of adverse events related to opioids.

Conditions

Interventions

TypeNameDescription
DRUGMethadone HydrochlorideClassic induction of anesthesia (opioid, hypnotic and curare) but the team is blinded to the opioid used (sufentanil or methadone), which is prepared in identical syringes by the pharmacy
DRUGSufentanil CitrateClassic induction of anesthesia (opioid, hypnotic and curare) but the team is blinded to the opioid used (sufentanil or methadone), which is prepared in identical syringes by the pharmacy

Timeline

Start date
2023-02-28
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-04-26
Last updated
2025-02-07

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05831345. Inclusion in this directory is not an endorsement.